About this trial
The objective of the Pediatric Epidemiological Data and Incidence (PEDI) PANDAS study is to demonstrate the feasibility of enrollment and retention of subjects in a study to determine the incidence and natural history of children with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) with regard to spectrum, course and outcome. The investigators aim to demonstrate they can recruit and retain 85% of children who are eligible for this study. Eligible children are those who fit criteria for PANS and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus (PANDAS). Each child will be followed for one year.
Eligibility criteria
Qualifiers
Child age 3-17 years old
Child and their parent/guardian are able to complete all study activities in English
Potential participant's family plans to be followed within UW Health or Dartmouth Health for at least one year
Pediatric patient who is a current member of the primary care population at either UW Health or Dartmouth Health
Disqualifiers
History of tics, OCD or food restriction/avoidance that contradicts a history of sudden onset or was present before the onset of this investigation
Current symptom(s) of Pica
Previous participation in the study
Not suitable for study participation at the discretion of the site investigator (e.g., the child does not have verbal or cognitive ability adequate for self-report assessment)
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
University of Wisconsin, Madison
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator